Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104605) titled 'Study to Assess the Benefit of LM Potency Homeopathic Medicines in Treating Eczema' on Feb. 24.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: C D Pachchigar College of Homeopathic Medicine And Hospital
Condition:
Health Condition 1: L309- Dermatitis, unspecified
Intervention:
Intervention1: Individulised Homoeopathic Medicine: Individualized homoeopathic treatment will be administered using LM (50 millesimal) potency selected on the ...